New Non-invasive Modalities for Assessing Retinal Structure and Function
Randy Kardon · NCT03475173
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–99 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 500
- US sites recruiting
- 1
- Study start
- May 6, 2019
- Record last updated
- September 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study investigates a new technology to assess the structure and function inside the eye. Retinal imaging of subjects with inner and outer retinal defects to detect areas of abnormal structure and function compared to other visual function tests.
Being studied: LSFG-NAVI
Conditions: Ischemic Optic Neuropathy; Branch Retinal Artery Occlusion; Hemianopia; Leber Hereditary Optic Neuropathy; Acute Zonal Occult Outer Retinopathy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Controls
Inclusion
Normal eye exam in last 2 years
Exclusion
Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay. Any abnormalities of the retina or optic nerve that could affect metabolism of the retina outside of normal.
Subjects with Inner Retina Defect
Inclusion
Defined structural defect to include those with Ischemic optic neuropathy, branch retinal artery occlusion (BRAO), hemianopia or visual field defect that respects the vertical meridian, inherited mitochondrial optic neuropathies such as Leber's and Dominant Optic Neuropathy, other retinopathies or optic neuropathies.
Exclusion
Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
Subjects with Outer Retinal Defect
Inclusion
AZOOR (acute zonal occult outer retinopathy) or other focal or diffuse outer photoreceptor loss of function
Exclusion
Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
The 450 total is to allow for exclusion of some subjects or in the event that the enrolled subject blinks too much or cannot fixate on a visual target adequately to maintain the same eye position during the short imaging interval. We hope to have a total of 450 (50 controls and 400 patients)
Recruiting US locations
University of Iowa Department of Ophthalmology
Iowa City, IA 52242
Site contact: Denise L Rettig, MHA. MBA · 319-356-2866 · denise-rettig@uiowa.edu
Study contacts (from the official record)
- Julie K Nellis, BSN · 319-356-8299 · julie-nellis@uiowa.edu
- Jan M Full, BSN · 319-356-8299 · jan-full@uiowa.edu
Similar studies in Iowa
All neurology studies in Iowa →- RecruitingHealthy volunteers
An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury
Rebiscan, Inc.
- Location
- Waukee, IA
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Iowa City, IA + 35 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions
RapidPulse, Inc
- Location
- Iowa City, IA + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- West Des Moines, IA + 111 other US sites
- Eligibility basics
- Ages 18+